Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
- Previous Close
7.26 - Open
6.95 - Bid 7.18 x --
- Ask 7.19 x --
- Day's Range
7.15 - 7.28 - 52 Week Range
5.93 - 8.68 - Volume
32,985,570 - Avg. Volume
35,528,434 - Market Cap (intraday)
47.781B - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
23.19 - EPS (TTM)
0.31 - Earnings Date --
- Forward Dividend & Yield 0.03 (0.42%)
- Ex-Dividend Date Jun 13, 2023
- 1y Target Est
--
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.
www.raas-corp.comRecent News: 002252.SZ
Performance Overview: 002252.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002252.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002252.SZ
Valuation Measures
Market Cap
47.78B
Enterprise Value
43.55B
Trailing P/E
23.34
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.38
Price/Book (mrq)
1.60
Enterprise Value/Revenue
5.77
Enterprise Value/EBITDA
17.55
Financial Highlights
Profitability and Income Statement
Profit Margin
27.33%
Return on Assets (ttm)
4.43%
Return on Equity (ttm)
7.03%
Revenue (ttm)
7.55B
Net Income Avi to Common (ttm)
2.06B
Diluted EPS (ttm)
0.31
Balance Sheet and Cash Flow
Total Cash (mrq)
4.24B
Total Debt/Equity (mrq)
0.01%
Levered Free Cash Flow (ttm)
2.14B
Research Analysis: 002252.SZ
Company Insights: 002252.SZ
002252.SZ does not have Company Insights